Analysts think BBLG stock price could increase by 631%
Aug 02, 2024, 6:25 AM
-48.16%
What does BBLG do
Bone Biologics Corp, headquartered in Burlington, Massachusetts with 2 employees, focuses on bone regeneration in spinal fusion using NELL-1, a recombinant human protein. The company, which went public in 2015, develops technologies for various bone-related medical procedures.
3 analysts think BBLG stock price will increase by 631.25%. The current median analyst target is $19.89 compared to a current stock price of $2.72. The lowest analysts target is $19.70 and the highest analyst target is $20.48.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
